Apollon Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.54M | Sell |
187,356
-4,489
| -2% | -$109K | 0.09% | 198 |
|
2025
Q1 | $4.86M | Sell |
191,845
-10,183
| -5% | -$258K | 0.11% | 174 |
|
2024
Q4 | $5.36M | Buy |
202,028
+246
| +0.1% | +$6.53K | 0.12% | 145 |
|
2024
Q3 | $5.84M | Sell |
201,782
-11,718
| -5% | -$339K | 0.17% | 108 |
|
2024
Q2 | $5.97M | Sell |
213,500
-11,525
| -5% | -$322K | 0.18% | 104 |
|
2024
Q1 | $6.24M | Buy |
225,025
+36,424
| +19% | +$1.01M | 0.2% | 94 |
|
2023
Q4 | $5.43M | Buy |
188,601
+8,457
| +5% | +$243K | 0.19% | 96 |
|
2023
Q3 | $5.98M | Sell |
180,144
-4,734
| -3% | -$157K | 0.3% | 64 |
|
2023
Q2 | $6.78M | Buy |
184,878
+8,424
| +5% | +$309K | 0.33% | 60 |
|
2023
Q1 | $7.2M | Sell |
176,454
-4,323
| -2% | -$176K | 0.44% | 43 |
|
2022
Q4 | $9.26M | Buy |
180,777
+16,184
| +10% | +$829K | 0.66% | 21 |
|
2022
Q3 | $7.2M | Buy |
164,593
+248
| +0.2% | +$10.9K | 0.59% | 27 |
|
2022
Q2 | $8.62M | Buy |
164,345
+4,139
| +3% | +$217K | 0.72% | 21 |
|
2022
Q1 | $8.29M | Sell |
160,206
-9,970
| -6% | -$516K | 0.59% | 26 |
|
2021
Q4 | $10M | Buy |
170,176
+66,309
| +64% | +$3.92M | 0.75% | 19 |
|
2021
Q3 | $4.47M | Buy |
103,867
+59,397
| +134% | +$2.55M | 0.61% | 33 |
|
2021
Q2 | $1.74M | Sell |
44,470
-3,671
| -8% | -$144K | 0.31% | 56 |
|
2021
Q1 | $1.74M | Buy |
48,141
+39,538
| +460% | +$1.43M | 0.34% | 58 |
|
2020
Q4 | $317K | Sell |
8,603
-12,087
| -58% | -$445K | 0.09% | 154 |
|
2020
Q3 | $720K | Buy |
20,690
+7,567
| +58% | +$263K | 0.32% | 73 |
|
2020
Q2 | $407K | Buy |
+13,123
| New | +$407K | 0.22% | 61 |
|
2020
Q1 | – | Sell |
-5,648
| Closed | -$211K | – | 76 |
|
2019
Q4 | $211K | Buy |
+5,648
| New | +$211K | 0.19% | 68 |
|
2019
Q3 | – | Sell |
-1,241
| Closed | -$51K | – | 95 |
|
2019
Q2 | $51K | Buy |
+1,241
| New | +$51K | 0.06% | 96 |
|